Bortezomib and High-dose Melphalan at Myeloma Relapse

Clinical trial NCT00508209 · UNKNOWN

Trial details

NCT number: NCT00508209
Sponsor: Nordic Myeloma Study Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2007-07-01
Primary completion: 2009-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.